Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.
Homin KangJungyo SuhDalsan YouIn Gab JeongBumsik HongJun Hyuk HongHanjong AhnBumjin LimPublished in: Investigative and clinical urology (2024)
Thus, older age and presence of DM are potential risk factors for GP NAC discontinuation in patients with MIBC. Further studies are required to validate our findings and develop strategies to minimize the rate of GP NAC discontinuation in this population.
Keyphrases
- early stage
- neoadjuvant chemotherapy
- sentinel lymph node
- locally advanced
- end stage renal disease
- muscle invasive bladder cancer
- transcription factor
- ejection fraction
- chronic kidney disease
- newly diagnosed
- lymph node
- prognostic factors
- physical activity
- peritoneal dialysis
- type diabetes
- rectal cancer
- radiation therapy
- metabolic syndrome
- patient reported outcomes
- middle aged
- adipose tissue
- weight loss